Summary
TetraGenetics
Founded in 2004
Description
Using ciliate Tetrahymena to produce high-quality biologics, vaccines, and diagnostic tools to improve Global Health. Gates Grand Challenge Grant winner.
Strengths
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
Weaknesses
- TetraGenetics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Since TetraGenetics was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
TetraGenetics's annual revenue
$2424000
Based on Kona Equity data
-
Revenue per employee
$186462
-
Variance of revenue growth
0.01
-
Annual revenue growth since founding
$121200
-
Revenue growth rate from first known quarter to current
49.1%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
54.5%
Executives
Jeff Steinbach
Controller
j**@tetragenetics.comKevin O'Brien
Chief Financial Officer
k**@tetragenetics.comSarita Khanal
Research Associate I
s**@tetragenetics.comEllen Gulezian
Research Associate
e**@tetragenetics.comPaul Colussi
Vice President, Research
p**@tetragenetics.comAshot Papoyan
Associate Director
a**@tetragenetics.comSunyia Hussain
Manager and Lead Scientist, Protein Biochemistry Group
s**@tetragenetics.comDoug Kahn
CEO
d**@tetragenetics.comCasey Fraher
Laboratory Technician
c**@tetragenetics.comJanna Bednenko
Head of Protein Expression and Genetics
j**@tetragenetics.comJoanna Cardarelli
Project Manager
j**@tetragenetics.comMelissa Ramos
Manager, Office
m**@tetragenetics.comPhone Tetragenetics
Chairman & Chief Executive Officer
p**@tetragenetics.comKevin Brien
Chief Financial Officer
k**@tetragenetics.comClaudia Zafra
Research Associate
c**@tetragenetics.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
Location
Unlock unlimited leads
Similar Companies
Trellis Bioscience LLC
trellisbio.com- Location: Redwood City, CA
- Annual Revenue: $3.6M
- Employees: 11
- Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
AvantGen Inc
avantgen.com- Founded in 2006
- Location: San Diego, CA
- Annual Revenue: $2.9M
- Employees: 14
- AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. With its proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner) libraries and screening technologies, AvantGen's Therapeutic Division i…
Pandion Therapeutics
pandiontx.com- Founded in 2016
- Location: Watertown, MA
- Annual Revenue: $1.0M
- Employees: 40
Compass Therapeutics
compasstherapeutics.com- Founded in 2014
- Location: Boston, MA
- Annual Revenue: $5.1M
- Employees: 24
- Compass Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody-based therapeutics to treat multiple human diseases. Their scientific focus is on the relationship between angiogenesis, the immune system, and tumor grow...
Pharmos
pharmoscorp.com- Founded in 1982
- Location: North Las Vegas, NV
- Annual Revenue: $908.0K
- Employees: 2
- Pharmos Corporation is a bio-pharmaceutical company that discovers and develops new drugs to treat a range of neuroinflammatory disorders.
Apexigen Inc
apexigen.com- Location: San Carlos, CA
- Annual Revenue: $4.2M
- Employees: 20
- Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Key Information
- Name: TetraGenetics
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 283; 28
- NAICS: 5417; 541
See similar companies
-
By City Arlington Small Biotechnology Company in Arlington Mid-size Biotechnology Company in Arlington Biotechnology in Arlington Small Biotechnology in Arlington Mid-size Biotechnology in Arlington
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 3 Founded in 2004 SIC: 283 SIC: 28 NAICS: 5417 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
TetraGenetics's headquarters are located at 91 Mystic St Arlington, MA 02474.
TetraGenetics's official website is tetragenetics.com
TetraGenetics's annual revenue is $2.4 M.
TetraGenetics's SIC: 283; 28
TetraGenetics's NAICS: 5417; 541.
TetraGenetics has 13 employees
TetraGenetics is in the industry of Biotechnology.
